Next Generation Immunotherapy Market Surge: Projected CAGR of 7.5% from 2024 to 2029

Posted by Akio Komatsu on December 3rd, 2024

Market Overview: Next Generation Immunotherapy Market FY23-28

This reports provides an essential and dependable overview of the Next Generation Immunotherapy Market, serving as a guide for stakeholders navigating the industry's future trajectory. It covers critical aspects, guiding through challenges and opportunities, shedding light on the market landscape, key insights, driving forces, major competitors, regulatory framework, potential growth, ongoing trends, supply chain dynamics, evolving policies, segments and prominent players.

Next Generation Immunotherapy Market Report Coverage Details:

  • Base Year: 2023
  • Historical Data: 2019-22
  • Forecast Period: 2024-2029
  • CAGR5% (2024-2029)

Global Next Generation Immunotherapy Market is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2024-29.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Boost strategic growth with in-depth market analysis - Get a free sample preview today!- https://www.marknteladvisors.com/query/request-sample/next-generation-immunotherapy-market.html  

Next Generation Immunotherapy Market Opportunity:

Development and Commercialization of Personalized Cancer Vaccines – The progress and commercialization of personalized cancer vaccines represent a significant opportunity driven by advances in genomics and molecular biology. Leading companies such as BioNTech, Moderna, and AstraZeneca are pioneering these innovative therapies, harnessing mRNA technology and other cutting-edge approaches.

Moreover, there is a growing awareness among consumers, particularly in countries like the US, India, and the UK, about the superior efficacy of personalized cancer vaccines compared to traditional ones. In addition to increasing awareness, the rising incidence of cancers like breast cancer and ovarian cancer in countries such as China, Canada, and Australia due to various factors, including lifestyle, environmental conditions, and genetic mutations, will drive the demand for personalized medicines in the coming years.

Furthermore, the global personalized cancer vaccines market is poised for significant growth, with pharmaceutical companies worldwide heavily investing in research and development. For Instance,

  • In 2023, BioNTech and Roche's personalized cancer vaccine Phase I trial data was published in Nature offering promising potential for improving outcomes in lethal pancreatic ductal adenocarcinoma.

This represents a noteworthy advancement in personalized cancer vaccine development and holds the potential to revolutionize cancer treatment and create significant opportunities for market growth.

Next Generation Immunotherapy Market Segmentation Analysis - FY23-28

Discover a comprehensive evaluation of every segment and its subdivisions, allowing our clients to gain a deep understanding of the Next Generation Immunotherapy Market (2024-29). We prioritize uncovering the pivotal factors that presently drive and will shape the industry's growth moving forward. Our goal is to empower our esteemed clients by optimizing their end-user positioning and revenue generation through a thorough analysis of market size, share and all the latest market scope across diverse segmentation categories.

The Next Generation Immunotherapy Market segmentation is enlisted below:

By Type

  • Vaccines- Market Size & Forecast 2019-2029F, USD Million
    • mRNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
    • DNA Vaccines- Market Size & Forecast 2019-2029F, USD Million
    • Protein Vaccines- Market Size & Forecast 2019-2029, USD Million
    • Others (Viral Vector Vaccines, Nanoparticle Vaccines, etc.)- Market Size & Forecast 2019-2029, USD Million
  • Immune Checkpoint Modulators- Market Size & Forecast 2019-2029F, USD Million
  • CAR-T Cell Therapy- Market Size & Forecast 2019-2029F, USD Million
  • Tumor-Infiltrating Lymphocytes (TILs) Therapy- Market Size & Forecast 2019-2029F, USD Million
  • Bispecific Antibodies- Market Size & Forecast 2019-2029F, USD Million
  • Oncolytic Virus Therapy- Market Size & Forecast 2019-2029F, USD Million
  • Others (Antibody-drug Conjugates, ACE Inhibitors, etc.)- Market Size & Forecast 2019-2029F, USD Million

By Route of Administration

  • Intravenous- Market Size & Forecast 2019-2029F, USD Million
  • Intratumoral- Market Size & Forecast 2019-2029F, USD Million
  • Subcutaneous- Market Size & Forecast 2019-2029F, USD Million
  • Oral- Market Size & Forecast 2019-2029F, USD Million

Among them, in recent years, the approach for intratumoral administration has surged in popularity due to its ability to elicit a stronger immune response, backed by promising clinical findings.

By Therapeutic Area

  • Oncology- Market Size & Forecast 2019-2029F, USD Million
  • Autoimmune Diseases- Market Size & Forecast 2019-2029F, USD Million
  • Infectious Diseases- Market Size & Forecast 2019-2029F, USD Million
  • Inflammatory Diseases- Market Size & Forecast 2019-2029F, USD Million
  • Others (Neurological Disorders, B-cell Malignancies, etc.) - Market Size & Forecast 2019-2029F, USD Million

By End User

  • Hospitals- Market Size & Forecast 2019-2029F, USD Million
  • Specialty Clinics- Market Size & Forecast 2019-2029F, USD Million
  • Ambulatory Surgical Centres- Market Size & Forecast 2019-2029F, USD Million
  • Cancer Research Centres- Market Size & Forecast 2019-2029F, USD Million

Buy specific sections of the report directly from the Table of Contents - https://www.marknteladvisors.com/research-library/next-generation-immunotherapy-market.html

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Next Generation Immunotherapy Market Competitive Landscape

Bristol Myers Squibb, Regeneron Pharmaceuticals, MacroGenics, AbbVie Inc., Pfizer Inc., Novartis, Merck  & Co., Inc., AstraZeneca, Incyte Corporation, Eli Lilly and Company, Johnson and Johnson, Others.

Next Generation Immunotherapy Industry News:

  • 2023: Boehringer Ingelheim and 3T Biosciences have formed a strategic collaboration to leverage 3T Biosciences' 3T-TRACE discovery platform and Boehringer Ingelheim's research expertise to develop next-generation cancer therapies. Boehringer Ingelheim will supply patient-derived TCR data to support 3T's antigen discovery using the TRACE platform, with 3T receiving initial payment and research backing.

Key Report Highlights   

  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Other Trending Reports 

https://tach-amit.blogspot.com/2024/12/exploring-identity-verification-market.html 

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Our Expertise is here to assist you : https://www.marknteladvisors.com/query/talk-to-our-consultant/next-generation-immunotherapy-market.html

Call Us - US Office: +1 628 895 8081, India Office: +91 120 4278433

Email - sales@marknteladvisors.com

Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

 

Like it? Share it!


Akio Komatsu

About the Author

Akio Komatsu
Joined: August 6th, 2024
Articles Posted: 321

More by this author